These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 11097836)

  • 41. BCAP 31 expression and promoter demethylation in psoriasis.
    Ruchusatsawat K; Thiemsing L; Mutirangura A; Wongpiyabovorn J
    Asian Pac J Allergy Immunol; 2017 Jun; 35(2):86-90. PubMed ID: 27996285
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Emerging role of IκBζ in inflammation: Emphasis on psoriasis.
    Gautam P; Maenner S; Cailotto F; Reboul P; Labialle S; Jouzeau JY; Bourgaud F; Moulin D
    Clin Transl Med; 2022 Oct; 12(10):e1032. PubMed ID: 36245291
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression of IL-36 family cytokines and IL-37 but not IL-38 is altered in psoriatic skin.
    Keermann M; Kõks S; Reimann E; Abram K; Erm T; Silm H; Kingo K
    J Dermatol Sci; 2015 Nov; 80(2):150-2. PubMed ID: 26319074
    [No Abstract]   [Full Text] [Related]  

  • 44. The caspase-cleaved form of LYN mediates a psoriasis-like inflammatory syndrome in mice.
    Marchetti S; Gamas P; Belhacène N; Grosso S; Pradelli LA; Colosetti P; Johansen C; Iversen L; Deckert M; Luciano F; Hofman P; Ortonne N; Khemis A; Mari B; Ortonne JP; Ricci JE; Auberger P
    EMBO J; 2009 Aug; 28(16):2449-60. PubMed ID: 19590497
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Potential synergy between SNP and CpG-A or IL-1β in regulating transcriptional activity of IL-20 promoter.
    Wang L; Li K; Xu Q; Chen X; Xue F; Shi R; Zheng J
    J Invest Dermatol; 2014 Feb; 134(2):389-395. PubMed ID: 23892591
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Leptin induces altered differentiation of keratinocytes by inducing insulin resistance: implications for metabolic syndrome-induced resistance of psoriatic therapy.
    Wang R; Yu C; Tang Z; Sun J; Wang Y; Zhao Z; Lin B; Li C
    J Dermatolog Treat; 2024 Dec; 35(1):2309305. PubMed ID: 38297481
    [No Abstract]   [Full Text] [Related]  

  • 47. Interleukin 10 promotor gene polymorphism in the pathogenesis of psoriasis.
    Isac L; Jiquan S
    Acta Dermatovenerol Alp Pannonica Adriat; 2019 Sep; 28(3):119-123. PubMed ID: 31545389
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The central inflammatory regulator IκBζ: induction, regulation and physiological functions.
    Feng Y; Chen Z; Xu Y; Han Y; Jia X; Wang Z; Zhang N; Lv W
    Front Immunol; 2023; 14():1188253. PubMed ID: 37377955
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dysregulated expression of inflammation-related genes in psoriatic dermis mesenchymal stem cells.
    Niu X; Zhang K
    Acta Biochim Biophys Sin (Shanghai); 2016 Jun; 48(6):587-8. PubMed ID: 27151294
    [No Abstract]   [Full Text] [Related]  

  • 50. Leptin induces interleukin-6 production in keratinocytes via decreased expression of caveolin-1: a possible link between obesity and psoriatic inflammation.
    Watanabe Y; Yamaguchi Y; Takamura N; Komitsu N; Aihara M
    Br J Dermatol; 2020 Oct; 183(4):768-770. PubMed ID: 32294231
    [No Abstract]   [Full Text] [Related]  

  • 51. Clinical significance of circulating exosomal interleukin-23 and tumour necrosis factor-α messenger RNA in psoriasis.
    Sawamura S; Tselmeg Mijiddorj M; Kajihara I; Shimada S; Kanemaru H; Yamada-Kanazawa S; Makino K; Aoi J; Masuguchi S; Fukushima S
    J Eur Acad Dermatol Venereol; 2023 Jun; 37(6):e815-e817. PubMed ID: 36734603
    [No Abstract]   [Full Text] [Related]  

  • 52. Novel factors in the pathogenesis of psoriasis and potential drug candidates are found with systems biology approach.
    Manczinger M; Kemény L
    PLoS One; 2013; 8(11):e80751. PubMed ID: 24303025
    [TBL] [Abstract][Full Text] [Related]  

  • 53. NFκB inhibitors as a potential novel hypothesized treatment for psoriasis.
    Derakhshan N
    Sao Paulo Med J; 2011 Dec; 129(6):433-4. PubMed ID: 22249801
    [No Abstract]   [Full Text] [Related]  

  • 54. Possible role of NFkappaB in the embryonic vascular remodeling and the endothelial mesenchymal transition process.
    Arciniegas E; Carrillo LM; De Sanctis JB; Candelle D
    Cell Adh Migr; 2008; 2(1):17-29. PubMed ID: 19262121
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Insulin-like growth factor II induces interleukin-6 expression via NFkappaB activation in psoriasis.
    Kwon YW; Jang ER; Lee YM; Kim YS; Kwon KS; Jang HS; Oh CK; Kim KW
    Biochem Biophys Res Commun; 2000 Nov; 278(2):312-7. PubMed ID: 11097836
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differential regulation of IGF-II-induced IL-8 by extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinases in human keratinocytes.
    Kim HJ; Byun SJ; Kim TY
    Biochem Biophys Res Commun; 2004 Apr; 317(1):276-84. PubMed ID: 15047180
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Regulation of vascular endothelial growth factor expression by insulin-like growth factor-II in human keratinocytes, differential involvement of mitogen-activated protein kinases and feedback inhibition of protein kinase C.
    Kim HJ; Kim TY
    Br J Dermatol; 2005 Mar; 152(3):418-25. PubMed ID: 15787809
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Insulin-like growth factor-I augments interleukin-8 promoter activity through induction of activator protein-1 complex formation.
    Kooijman R; Coppens A; Van den Keybus C
    Int J Biochem Cell Biol; 2006; 38(11):1957-64. PubMed ID: 16846747
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression and function of interleukin-6 in epithelial cells.
    Krueger J; Ray A; Tamm I; Sehgal PB
    J Cell Biochem; 1991 Apr; 45(4):327-34. PubMed ID: 2045425
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.